Literature DB >> 5901320

Cyclophosphamide in the treatment of systemic lupus erythematosus.

C Siang, K H Wong, A G Chew, F J Jayaratnam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5901320      PMCID： PMC1843708          DOI： 10.1136/bmj.1.5483.333

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  IDIOPATHIC AUTOIMMUNE HEMOLYTIC ANEMIA. RESPONSE OF A PATIENT TO REPEATED COURSES OF ALKYLATING AGENTS.

Authors:  L TAYLOR
Journal:  Am J Med       Date:  1963-07       Impact factor: 4.965

2.  TREATMENT OF ACTIVE CHRONIC HEPATITIS AND LUPOID HEPATITIS WITH 6-MERCAPTOPURINE AND AZOTHIOPRINE.

Authors:  I R MACKAY; S WEIDEN; B UNGAR
Journal:  Lancet       Date:  1964-04-25       Impact factor: 79.321

3.  The treatment of autoimmune hemolytic anemia with 6-mercaptopurine and thioguanine.

Authors:  R SCHWARTZ; W DAMESHEK
Journal:  Blood       Date:  1962-04       Impact factor: 22.113

4.  Treatment of certain "autoimmune" diseases with antimetabolites; a preliminary report.

Authors:  W DAMESHEK; R SCHWARTZ
Journal:  Trans Assoc Am Physicians       Date:  1960

5.  Some factors influencing the formation of L.E. cells; a method for enhancing L.E. cell production.

Authors:  W H ZINKHAM; C L CONLEY
Journal:  Bull Johns Hopkins Hosp       Date:  1956-02
  5 in total
  10 in total

1.  Mortality in systemic lupus erythematosus: a 10-year review.

Authors:  P H Feng; P S Cheah; Y K Lee
Journal:  Br Med J       Date:  1973-12-29

2.  Cyclophosphamide in systemic lupus erythematosus.

Authors:  T Hadidi
Journal:  Ann Rheum Dis       Date:  1970-11       Impact factor: 19.103

3.  Effects of cyclophosphamide o immune arthritis in the guinea-pig.

Authors:  J M Gumpel; P M Ford; F W Webb
Journal:  Ann Rheum Dis       Date:  1971-01       Impact factor: 19.103

4.  Cyclophosphamide and whole organ transplantation in human beings.

Authors:  T E Starzl; C W Putnam; C G Halgrimson; G T Schroter; G Martineau; B Launois; J L Corman; I Penn; A S Booth; C G Groth; K A Porter
Journal:  Surg Gynecol Obstet       Date:  1971-12

5.  Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.

Authors:  R H White; J S Cameron; J R Trounce
Journal:  Br Med J       Date:  1966-10-08

6.  Immunosupressive or anti-inflammatory?

Authors: 
Journal:  Br Med J       Date:  1967-03-18

Review 7.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 8.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

9.  Cyclophosphamide in treatment of systemic lupus erythematosus: 7 years' experience.

Authors:  P H Feng; F J Jayaratnam; E P Tock; C S Seah
Journal:  Br Med J       Date:  1973-05-26

10.  Psychosis in systemic lupus erythematosus (SLE) and the response to cyclophosphamide.

Authors:  C G Brook; P R Evans
Journal:  Proc R Soc Med       Date:  1969-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.